These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17471236)

  • 1. SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
    Donatello S; Fiorino A; Degl'Innocenti D; Alberti L; Miranda C; Gorla L; Bongarzone I; Rizzetti MG; Pierotti MA; Borrello MG
    Oncogene; 2007 Oct; 26(45):6546-59. PubMed ID: 17471236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.
    Gujral TS; van Veelen W; Richardson DS; Myers SM; Meens JA; Acton DS; Duñach M; Elliott BE; Höppener JW; Mulligan LM
    Cancer Res; 2008 Mar; 68(5):1338-46. PubMed ID: 18316596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
    Lodyga M; De Falco V; Bai XH; Kapus A; Melillo RM; Santoro M; Liu M
    Oncogene; 2009 Feb; 28(7):937-49. PubMed ID: 19060924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.
    Asai N; Jijiwa M; Enomoto A; Kawai K; Maeda K; Ichiahara M; Murakumo Y; Takahashi M
    Pathol Int; 2006 Apr; 56(4):164-72. PubMed ID: 16634961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the RET pathway in thyroid cancer.
    Wells SA; Santoro M
    Clin Cancer Res; 2009 Dec; 15(23):7119-23. PubMed ID: 19934298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
    Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
    Iervolino A; Iuliano R; Trapasso F; Viglietto G; Melillo RM; Carlomagno F; Santoro M; Fusco A
    Cancer Res; 2006 Jun; 66(12):6280-7. PubMed ID: 16778204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.
    Akeno-Stuart N; Croyle M; Knauf JA; Malaguarnera R; Vitagliano D; Santoro M; Stephan C; Grosios K; Wartmann M; Cozens R; Caravatti G; Fabbro D; Lane HA; Fagin JA
    Cancer Res; 2007 Jul; 67(14):6956-64. PubMed ID: 17638907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells.
    Schuetz G; Rosário M; Grimm J; Boeckers TM; Gundelfinger ED; Birchmeier W
    J Cell Biol; 2004 Dec; 167(5):945-52. PubMed ID: 15569713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell migration by a FRS2-adaptor dependent membrane relocation of ret receptors.
    Lundgren TK; Stenqvist A; Scott RP; Pawson T; Ernfors P
    J Cell Biochem; 2008 Jun; 104(3):879-94. PubMed ID: 18189271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grap-2, a novel RET binding protein, is involved in RET mitogenic signaling.
    Ludwig L; Kessler H; Hoang-Vu C; Dralle H; Adler G; Boehm BO; Schmid RM
    Oncogene; 2003 Aug; 22(34):5362-6. PubMed ID: 12917638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.
    De Falco V; Guarino V; Malorni L; Cirafici AM; Troglio F; Erreni M; Pelicci G; Santoro M; Melillo RM
    Oncogene; 2005 Sep; 24(41):6303-13. PubMed ID: 15940252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
    Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
    Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo.
    Fischer I; Schulze S; Kuhn C; Friese K; Walzel H; Markert UR; Jeschke U
    Placenta; 2009 Dec; 30(12):1078-82. PubMed ID: 19900702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Shc docking site on Ret tyrosine kinase.
    Arighi E; Alberti L; Torriti F; Ghizzoni S; Rizzetti MG; Pelicci G; Pasini B; Bongarzone I; Piutti C; Pierotti MA; Borrello MG
    Oncogene; 1997 Feb; 14(7):773-82. PubMed ID: 9047384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET inhibition: implications in cancer therapy.
    Borrello MG; Ardini E; Locati LD; Greco A; Licitra L; Pierotti MA
    Expert Opin Ther Targets; 2013 Apr; 17(4):403-19. PubMed ID: 23461584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.
    Vargiolu M; Fusco D; Kurelac I; Dirnberger D; Baumeister R; Morra I; Melcarne A; Rimondini R; Romeo G; Bonora E
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2571-8. PubMed ID: 19366855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain.
    Durick K; Wu RY; Gill GN; Taylor SS
    J Biol Chem; 1996 May; 271(22):12691-4. PubMed ID: 8662982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.
    Bagheri-Yarmand R; Sinha KM; Gururaj AE; Ahmed Z; Rizvi YQ; Huang SC; Ladbury JE; Bogler O; Williams MD; Cote GJ; Gagel RF
    J Biol Chem; 2015 May; 290(18):11749-61. PubMed ID: 25795775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression.
    Balogh K; Asa SL; Zheng L; Cassol C; Cheng S; Ezzat S
    Oncogene; 2012 Sep; 31(36):4012-21. PubMed ID: 22158039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.